BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31364002)

  • 1. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes.
    Vitiello GAF; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
    Breast Cancer Res Treat; 2019 Nov; 178(1):207-219. PubMed ID: 31364002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis.
    Vitiello GAF; Guembarovski RL; Hirata BKB; Amarante MK; de Oliveira CEC; de Oliveira KB; Cebinelli GCM; Guembarovski AL; Campos CZ; Watanabe MAE
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):645-655. PubMed ID: 29362917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations of polymorphisms of TGFB1 and TGFBR2 genes to genetic susceptibility to gastric cancer].
    Zhou Y; Jin GF; Jiang GJ; Wang HM; Tan YF; Ding WL; Wang LN; Chen WS; Ke Q; Shen J; Xu YC; Shen HB
    Ai Zheng; 2007 Jun; 26(6):581-5. PubMed ID: 17562261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta 1 polymorphisms and haplotypes associated with breast cancer susceptibility: A case-control study in Tunisian women.
    Hadj-Ahmed M; Ghali RM; Bouaziz H; Habel A; Stayoussef M; Ayedi M; Hachiche M; Rahal K; Yacoubi-Loueslati B; Almawi WY
    Tumour Biol; 2019 Aug; 41(8):1010428319869096. PubMed ID: 31405342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups.
    Vitiello GAF; Losi Guembarovski R; Amarante MK; Ceribelli JR; Carmelo ECB; Watanabe MAE
    Cytokine; 2018 Mar; 103():121-126. PubMed ID: 28964592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A link between promoter polymorphisms of the transforming growth factor β1 (TGFB1) and TGF-β1 receptor II (TGFBR2) genes and relapsing-remitting multiple sclerosis.
    Grigorova A; Trenova A; Stanilova S
    Folia Neuropathol; 2020; 58(4):307-316. PubMed ID: 33480235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population.
    Jin G; Deng Y; Miao R; Hu Z; Zhou Y; Tan Y; Wang J; Hua Z; Ding W; Wang L; Chen W; Shen J; Wang X; Xu Y; Shen H
    J Cancer Res Clin Oncol; 2008 Mar; 134(3):345-51. PubMed ID: 17680270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population.
    Jin G; Wang L; Chen W; Hu Z; Zhou Y; Tan Y; Wang J; Hua Z; Ding W; Shen J; Zhang Z; Wang X; Xu Y; Shen H
    Int J Cancer; 2007 Mar; 120(6):1330-5. PubMed ID: 17187359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming Growth Factor Beta Receptor 2 (TGFBR2) Promoter Region Polymorphisms May Be Involved in Mandibular Retrognathism.
    Kirschneck M; Zbidat N; Paddenberg E; Reis CLB; Madalena IR; de Menezes-Oliveira MAH; Lepri CP; Proff P; Kirschneck C; Küchler EC
    Biomed Res Int; 2022; 2022():1503052. PubMed ID: 35757474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G
    Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the TGFBR2 G-875A polymorphism and cancer risk: evidence from a meta-analysis.
    Huang YS; Zhong Y; Yu L; Wang L
    Asian Pac J Cancer Prev; 2014; 15(20):8705-8. PubMed ID: 25374194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional polymorphism of TGFBR2 is associated with risk of breast cancer with ER(+), PR(+), ER(+)PR(+) and HER2(-) expression in women.
    Zhang M; Guo LL; Cheng Z; Liu RY; Lu Y; Qian Q; Lei Z; Zhang HT
    Oncol Lett; 2011 Jul; 2(4):653-658. PubMed ID: 22848244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the TGFB1 -509C/T and TGFBR2 -875A/G polymorphisms and gastric cancer: a case-control study.
    Xu L; Zeng Z; Chen B; Wu X; Yu J; Xue L; Tian L; Wang Y; Chen M; Sung JJ; Hu P
    Oncol Lett; 2011 Mar; 2(2):371-377. PubMed ID: 22866090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness.
    Assis-Mendonça GR; Lourenço GJ; Delamain MT; de Lima VCC; Colleoni GWB; de Souza CA; Soares FA; Lima CSP; Vassallo J
    Blood Cancer J; 2020 Oct; 10(10):97. PubMed ID: 33024088
    [No Abstract]   [Full Text] [Related]  

  • 15. TGFβ-1 and TGFBR2 polymorphisms, cooking oil fume exposure and risk of lung adenocarcinoma in Chinese nonsmoking females: a case control study.
    Ren Y; Yin Z; Li K; Wan Y; Li X; Wu W; Guan P; Zhou B
    BMC Med Genet; 2015 Apr; 16():22. PubMed ID: 25928368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort.
    Vitiello GAF; de Sousa Pereira N; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1523-1532. PubMed ID: 32285256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of functional variant rs11466313 on breast cancer susceptibility and TGFB1 promoter activity.
    Zhou YT; Zheng LY; Wang YJ; Yang L; Xie YT; Panda I; Tian XX; Fang WG
    Breast Cancer Res Treat; 2020 Nov; 184(1):237-248. PubMed ID: 32757134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study.
    Cox DG; Penney K; Guo Q; Hankinson SE; Hunter DJ
    BMC Cancer; 2007 Sep; 7():175. PubMed ID: 17848193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
    McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
    BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.